Brief: Black Diamond Therapeutics Presents Preclinical Data On Bdtx-1535 And Bdtx-4933
26/10/2022 13:23
Oct 26 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS PRESENTS PRECLINICAL DATA ON
BDTX-1535 AND BDTX-4933 AT 34TH EORTC-NCI-AACR SYMPOSIUM ON
MOLECULAR TARGETS AND CANCER THERAPEUTICS
* BLACK DIAMOND THERAPEUTICS - EXPECTS TO PROVIDE A CLINICAL
UPDATE ON BDTX-1535 IN 2023
Source text for Eikon: ID:nGNX8rHV1j
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox